Morbidity and Associated Factors of Depressive Disorder in Patients With Parkinson's Disease.

Lee Y., Chiou Y-J., Chang Y-Y., Hung C-F., Chen Y-F., Lin T-K., Wang L-J.

Parkinson's disease (PD) is a progressive, neurodegenerative disorder and is commonly comorbid with depression. The aim of this cross-sectional study was to assess morbidity and associated factors of depression in patients with PD. In total, 181 patients with PD were enrolled and assessed using the Mini-International Neuropsychiatric Interview. Of the sample, 51% had at least one psychiatric diagnosis. The most prevalent psychiatric disorder was depressive disorder (27.6%), followed by rapid eye movement sleep behavior disorder (9.9%), insomnia disorder (8.8%), and adjustment disorder (2.8%). Severity of anxiety, suicide risk, and anxiolytics/hypnotics use were factors associated with depressive disorder in PD patients. Furthermore, severity of anxiety was significantly linked with suicide risk. We suggest that use of a standardized structured interview for early detection of depression in PD patients is crucial. Anxiety, anxiolytics/hypnotics use, depression, and suicide risks are interrelated and warrant clinical concerns regarding PD patients.

DOI

10.1097/NMD.0000000000001537

Type

Journal article

Publication Date

2022-10-01T00:00:00+00:00

Volume

210

Pages

777 - 783

Total pages

6

Keywords

Anti-Anxiety Agents, Cross-Sectional Studies, Depressive Disorder, Humans, Hypnotics and Sedatives, Morbidity, Parkinson Disease

Permalink More information Close